Interventions for attention problems after pediatric traumatic brain injury: What is the evidence?

PM and R

Volumn 6, Issue 9, 2014, Pages 814-824

  Backeljauw, Barynia ^a   Kurowski, Brad G ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; PIRACETAM;

ATTENTION; ATTENTION DISTURBANCE; CLINICAL TRIAL (TOPIC); COGNITION; COGNITIVE THERAPY; EVIDENCE BASED MEDICINE; HUMAN; INJURY SEVERITY; REVIEW; SYSTEMATIC REVIEW; TRAUMATIC BRAIN INJURY; TREATMENT INDICATION; TREATMENT OUTCOME; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN INJURIES; COMPLICATION;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN INJURIES; COGNITIVE THERAPY;

EID: 84908017775     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2014.04.004     Document Type: Review

References (63)

1. Faul M., Xu L., Wald M., Coronado V. Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations, and Deaths 2002-2006 2010, Centers for Disease Control and Prevention, National Center for Injury Prevention and Control, Atlanta, GA.
2. Beauchamp M., Catroppa C., Godfrey C., Morse S., Rosenfeld J.V., Anderson V. Selective changes in executive functioning ten years after severe childhood traumatic brain injury. Dev Neuropsychol 2011, 36:578-595.
3. Taylor H.G., Swartwout M.D., Yeates K.O., Walz N.C., Stancin T., Wade S.L. Traumatic brain injury in young children: postacute effects on cognitive and school readiness skills. JInt Neuropsychol Soc 2008, 14:734-745.
4. Nadebaum C., Anderson V., Catroppa C. Executive function outcomes following traumatic brain injury in young children: a five year follow-up. Dev Neuropsychol 2007, 32:703-728.
5. Anderson V., Eren S., Dob R., et al. Early attention impairment and recovery profiles after childhood traumatic brain injury. JHead Trauma Rehabil 2012, 27:199-209.
6. Catroppa C., Anderson V., Godfrey C., Rosenfeld J.V. Attentional skills 10 years post-paediatric traumatic brain injury (TBI). Brain Inj 2011, 25:858-869.
7. Anderson V., Catroppa C., Morse S., Haritou F., Rosenfeld J. Attentional and processing skills following traumatic brain injury in early childhood. Brain Inj 2005, 19:699-710.
8. Gerring J.P., Brady K.D., Chen A., et al. Premorbid prevalence of ADHD and development of secondary ADHD after closed head injury. JAm Acad Child Adolesc Psychiatry 1998, 37:647-654.
9. Levin H., Hanten G., Max J., et al. Symptoms of attention-deficit/hyperactivitydisorder following traumatic brain injury in children. JDev Behav Pediatr 2007, 28:108-118.
10. Max J.E., Lansing A.E., Koele S.L., et al. Attention deficit hyperactivity disorder in children and adolescents following traumatic brain injury. Dev Neuropsychol 2004, 25:159-177.
11. Wehmeier P.M., Schacht A., Barkley R.A. Social and emotional impairment in children and adolescents with ADHD and the impact on quality of life. JAdolesc Health 2010, 46:209-217.
12. Tsaousides T., Gordon W.A. Cognitive rehabilitation following traumatic brain injury: Assessment to treatment. Mt Sinai J Med 2009, 76:173-181.
13. Arciniegas D.B., Silver J.M. Pharmacotherapy of posttraumatic cognitive impairments. Behav Neurol 2006, 17:25-42.
14. Coulthard E., Singh-Curry V., Husain M. Treatment of attention deficits in neurological disorders. Curr Opin Neurol 2006, 19:613-618.
15. Michel J.A., Mateer C.A. Attention rehabilitation following stroke and traumatic brain injury. A review. Eura Medicophys 2006, 42:59-67.
16. Cicerone K.D., Dahlberg C., Malec J.F., et al. Evidence-based cognitive rehabilitation: updated review of the literature from 1998 through 2002. Arch Phys Med Rehabil 2005, 86:1681-1692.
17. Napolitano E., Elovic E.P., Qureshi A.I. Pharmacological stimulant treatment of neurocognitive and functional deficits after traumatic and non-traumatic brain injury. Med Sci Monit 2005, 11:RA212-RA220.
18. Siddall O.M. Use of methylphenidate in traumatic brain injury. Ann Pharmacother 2005, 39:1309-1313.
19. Jin C., Schachar R. Methylphenidate treatment of attention-deficit/hyperactivitydisorder secondary to traumatic brain injury: A critical appraisal of treatment studies. CNS Spectr 2004, 9:217-226.
20. Leonard B.E., McCartan D., White J., King D.J. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum Psychopharmacol 2004, 19:151-180.
21. Kajs-Wyllie M. Ritalin revisited: Does it really help in neurological injury?. JNeurosci Nurs 2002, 34:303-313.
22. Whyte J., Vaccaro M., Grieb-Neff P., Hart T. Psychostimulant use in the rehabilitation of individuals with traumatic brain injury. JHead Trauma Rehabil 2002, 17:284-299.
23. Cicerone K.D., Dahlberg C., Kalmar K., et al. Evidence-based cognitive rehabilitation: recommendations for clinical practice. Arch Phys Med Rehabil 2000, 81:1596-1615.
24. Cicerone K.D., Langenbahn D.M., Braden C., et al. Evidence-based cognitive rehabilitation: updated review of the literature from 2003 through 2008. Arch Phys Med Rehabil 2011, 92:519-530.
25. Sivan M., Neumann V., Kent R., Stroud A., Bhakta B.B. Pharmacotherapy for treatment of attention deficits after non-progressive acquired brain injury. A systematic review. Clin Rehabil 2010, 24:110-121.
26. Chew E., Zafonte R.D. Pharmacological management of neurobehavioral disorders following traumatic brain injury-a state-of-the-art review. JRehabil Res Dev 2009, 46:851-879.
27. Stiles J. Neural plasticity and cognitive development. Dev Neuropsychol 2000, 18:237-272.
28. Methods and Processes. U.S. Preventive Services Task Force. Available at: . Accessed: May 20, 2014. http://www.uspreventiveservicestaskforce.org/methods.htm.
29. Williams S.E., Ris M.D., Ayyangar R., Schefft B.K., Berch D. Recovery in pediatric brain injury: Is psychostimulant medication beneficial?. JHead Trauma Rehabil 1998, 13:73-81.
30. Mahalick D.M., Carmel P.W., Greenberg J.P., et al. Psychopharmacologic treatment of acquired attention disorders in children with brain injury. Pediatr Neurosurg 1998, 29:121-126.
31. Hornyak J.E., Nelson V.S., Hurvitz E.A. The use of methylphenidate in paediatric traumatic brain injury. Pediatr Rehabil 1997, 1:15-17.
32. Zavadenko N.N., Guzilova L.S. Sequelae of closed craniocerebral trauma and the efficacy of piracetam in its treatment in adolescents. Neurosci Behav Physiol 2009, 39:323-328.
33. Galbiati S., Recla M., Pastore V., et al. Attention remediation following traumatic brain injury in childhood and adolescence. Neuropsychology 2009, 23:40-49.
34. Thomas-Stonell N., Johnson P., Schuller R., Jutai J. Evaluation of a computer-based program for remediation of cognitive-communication skills. JHead Trauma Rehabil 1994, 9:25-37.
35. Catroppa C., Anderson V., Muscara F. Rehabilitation of executive skills post-childhood traumatic brain injury (TBI): A pilot intervention study. Dev Neurorehabil 2009, 12:361-369.
36. Sinopoli K.J., Schachar R., Dennis M. Traumatic brain injury and secondary attention-deficit/hyperactivity disorder in children and adolescents: the effect of reward on inhibitory control. JClin Exp Neuropsychol 2011, 33:805-819.
37. Konrad K., Gauggel S., Manz A., Scholl M. Lack of inhibition: A motivational deficit in children with attention deficit/hyperactivity disorder and children with traumatic brain injury. Child Neuropsychol 2000, 6:286-296.
38. Ho J., Epps A., Parry L., Poole M., Lah S. Rehabilitation of everyday memory deficits in paediatric brain injury: self-instruction and diary training. Neuropsychol Rehabil 2011, 21:183-207.
39. Sjö N.M., Spellerberg S., Weidner S., Kihlgren M. Training of attention and memory deficits in children with acquired brain injury. Acta Paediatr 2010, 99:230-236.
40. Hooft I.V., Andersson K., Bergman B., Sejersen T., Von Wendt L., Bartfai A. Beneficial effect from a cognitive training programme on children with acquired brain injuries demonstrated in a controlled study. Brain Inj 2005, 19:511-518.
41. van't Hooft I., Andersson K., Bergman B., Sejersen T., von Wendt L., Bartfai A. Sustained favorable effects of cognitive training in children with acquired brain injuries. NeuroRehabilitation 2007, 22:109-116.
42. de Kloet A.J., Berger M.A., Verhoeven I.M., van Stein Callenfels K., Vlieland T.P. Gaming supports youth with acquired brain injury? Apilot study. Brain Inj 2012, 26:1021-1029.
43. Evans S.W., Schultz B.K., Sadler J.M. Psychosocial interventions used to treat children with ADHD: Safety and efficacy. JPsychosoc Nurs Ment Health Serv 2008, 46:49-57.
44. Luman M., Oosterlaan J., Sergeant J.A. The impact of reinforcement contingencies on AD/HD: a review and theoretical appraisal. Clin Psychol Rev 2005, 25:183-213.
45. Couillet J., Soury S., Lebornec G., et al. Rehabilitation of divided attention after severe traumatic brain injury: a randomised trial. Neuropsychol Rehabil 2010, 20:321-339.
46. Woo B.S., Rey J.M. The validity of the DSM-IV subtypes of attention-deficit/hyperactivity disorder. Austr N Z J Psychiatry 2005, 39:344-353.
47. Solanto M., Newcorn J., Vail L., Gilbert S., Ivanov I., Lara R. Stimulant drug response in the predominantly inattentive and combined subtypes of attention-deficit/hyperactivity disorder. JChild Adolesc Psychopharmacol 2009, 19:663-671.
48. Sallee F.R., Kollins S.H., Wigal T.L. Efficacy of guanfacine extended release in the treatment of combined and inattentive only subtypes of attention-deficit/hyperactivity disorder. JChild Adolesc Psychopharmacol 2012, 22:206-214.
49. Grizenko N., Paci M., Joober R. Is the inattentive subtype of ADHD different from the combined/hyperactive subtype?. JAtten Disord 2010, 13:649-657.
50. Stein M.A., Sarampote C.S., Waldman I.D., et al. Adose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics 2003, 112:e404.
51. Gorman E.B., Klorman R., Thatcher J.E., Borgstedt A.D. Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder. JAm Acad Child Adolesc Psychiatry 2006, 45:808-816.
52. Barkley R.A., DuPaul G.J., McMurray M.B. Attention deficit disorder with and without hyperactivity: Clinical response to three dose levels of methylphenidate. Pediatrics 1991, 87:519-531.
53. Silver C.H. Ecological validity of neuropsychological assessment in childhood traumatic brain injury. JHead Trauma Rehabil 2000, 15:973-988.
54. Subcommittee on Attention-Deficit/Hyperactivity Disorder SeCoQI, Management ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics 2011, 128:1007-1022.
55. Kieling C., Genro J.P., Hutz M.H., Rohde L.A. Acurrent update on ADHD pharmacogenomics. Pharmacogenomics 2010, 11:407-419.
56. McGough J., McCracken J., Swanson J., et al. Pharmacogenetics of methylphenidate response in preschoolers with ADHD. JAm Acad Child Adolesc Psychiatry 2006, 45:1314-1322.
57. Froehlich T.E., Epstein J.N., Nick T.G., et al. Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder. JAm Acad Child Adolesc Psychiatry 2011, 50:1129-1139.e2.
58. McIntosh T.K. Neurochemical sequelae of traumatic brain injury: Therapeutic implications. Cerebrovasc Brain Metab Rev 1994, 6:109-162.
59. McAllister T.W., Flashman L.A., Sparling M.B., Saykin A.J. Working memory deficits after traumatic brain injury: catecholaminergic mechanisms and prospects for treatment-a review. Brain Inj 2004, 18:331-350.
60. McAllister T.W., Flashman L.A., McDonald B.C., Saykin A.J. Mechanisms ofworking memory dysfunction after mild and moderate TBI: evidence from functional MRI and neurogenetics. JNeurotrauma 2006, 23:1450-1467.
61. Kobori N., Clifton G.L., Dash P.K. Enhanced catecholamine synthesis in the prefrontal cortex after traumatic brain injury: Implications for prefrontal dysfunction. JNeurotrauma 2006, 23:1094-1102.
62. McAllister T.W. Polymorphisms in genes modulating the dopamine system: do they influence outcome and response to medication after traumatic brain injury?. JHead Trauma Rehabil 2009, 24:65-68.
63. Guillin O., Griffon N., Diaz J., et al. Brain-derived neurotrophic factor and the plasticity of the mesolimbic dopamine pathway. Int Rev Neurobiol 2004, 59:425-444.